Home » Newsletters » BioWorld Science

BioWorld Science

June 28, 2022

View Archived Issues

ON-203, a second-generation anti-oxMIF antibody with improved efficacy

RAC1 variants found to cause a novel developmental syndrome

LETM1 causes mitochondrial osmotic dysregulation tied to pathology

MagicMed Industries discloses new 5-HT2A receptor agonists

Suzhou Vincentage Pharma patents GLP-1 receptor agonists

Targeting of CD46 allows PET imaging of mesothelioma with [89Zr]DFO-YS5

Chengdu Easton Biopharmaceuticals discloses BET inhibitors

Chinese researchers identify new JAK1 inhibitors

IMPACT Therapeutics synthesizes new NUAK inhibitors

RBM22 inversely correlates with prostate cancer aggressiveness

EAN 2022: At several scales, connective landscape provides lens for neurology

New pH-responsive albumin-binding ligands show targeted tumor uptake in vivo

Use of [89Zr]Prot-FH for neutrophil imaging during fungal infection

Ainos reports preclinical data on low-dose oral interferon-alpha Veldona against COVID-19

Hillstream partners with Sapien to study synergy between HSB-1216 and immune checkpoint inhibitors

NCI grant supports Penn's development of intraoperative imaging technology for NSCLC

Kuria licenses rights to SCOHIA's SCO-116 for ocular and dermatologic diseases

Astellas and Sutro partner to discover and develop novel immunostimulatory antibody-drug conjugates

Ideaya selects Pol Theta Helicase development candidate

Confo awarded grant to support GPCR drug discovery

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...